FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis.

Abstract

FibroQ, a novel noninvasive test, is an useful and easy tool to evaluate liver fibrosis in patients with chronic viral hepatitis and has better accuracy than APRI and is equal to AAR. Further prospective studies are warranted to validate its efficacy.